OMB Control No: 0920-0572
ICR Reference No:
201502-0920-001
Status: Historical Active
Previous ICR Reference No: 201501-0920-003
Agency/Subagency: HHS/CDC
Agency Tracking No:
Title: CDC and ATSDR Health Message
Testing System
Type of Information Collection:
Extension without change of a currently approved collection
Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved
without change
Conclusion Date: 03/30/2015
Retrieve
Notice of Action (NOA)
Date Received in OIRA:
02/11/2015
Terms of Clearance: Approved
consistent with the following terms of clearance: For each
information collection, a GenIC information collection request will
be prepared and submitted to OMB for review and approval. Any
changes to the ICR will also be submitted to OMB for review and
approval.
Inventory as of this Action
Requested
Previously Approved
Expiration Date
03/31/2018
36 Months From Approved
03/31/2015
Responses
55,575
0
55,575
Time Burden (Hours)
7,410
0
7,510
Cost Burden (Dollars)
0
0
0
Abstract: CDC must communicate about hazards,
outbreaks and other emergencies that present an urgent health
threat to the public. Untested messages can waste communication
resources and opportunities because the messages can be perceived
as unclear or irrelevant. OADC-CDC requests an extension for the
generic clearance for an expedited review of items to be used in
health message testing to ensure the public will understand health
messages and take recommended action.
Authorizing Statute(s): US Code:
42
USC 241 Name of Law: Public Health Service Act
Citations for New Statutory
Requirements: None
Associated Rulemaking
Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices &
Comments
60-day Notice:
Federal Register Citation:
Citation Date:
79 FR
69478
11/21/2014
30-day Notice:
Federal Register Citation:
Citation Date:
80 FR
7477
02/10/2015
Did the Agency receive public comments on
this ICR? No
Number of Information Collection (IC) in this
ICR: 34
IC Title
Form No.
Form Name
HMTS - Formative
evaluation of Zika prevention strategies and messages among
pregnant women and community leaders in Puerto Rico
NA, NA, NA, NA, NA, NA
Focus Group
Discussion with Community Leaders in Puerto Rico to Explore
Possible Actions for Preventing Zika , Focus Group Discussion with
Pregnant Women in Puerto Rico to Explore Possible Actions for
Preventing Zika , Focus Group Discussion with
Pregnant Women in Puerto Rico To Test Zika Prevention Messages
, In-depth
Interview of Community Leaders in Puerto Rico to Explore Possible
Actions for Preventing Zika , In-depth Interview of Pregnant
Women in Puerto Rico to Explore Possible Actions for Preventing
Zika , In-depth Interview of Pregnant
Women in Puerto Rico To Test Zika Prevention Messages
High Impact Prevention
Message Testing (HIPMT)
NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA,
NA, NA, NA, NA
Consumer Focus
Group Guide , Consumer IDI Guide ,
Provider Focus Group
Guide , Provider IDI Guide ,
Professional Focus
Group Guide , Professional IDI Guide ,
Consumer - Brief
Survey , Provider - Brief Survey ,
Professional -
Brief Survey , Consumer - Screener ,
Provider -
Screener , Professional - Screener ,
Consumer -
Consent , Provider - Consent ,
Professional -
Consent , Consumer Web Survey ,
Intercept
Guide , Screener - Consumer Web
Survey , Consent - Consumer Web
Survey , Consent - Intercept
Survey
Asthma Control
Initiative Communication Messaging and Materials
Development
none
Focus Group Screener
GenIC Testing of
Spanish-language Messages for the National Diabetes
Domestic Readiness
Initiative on Zika Virus Disease
0920-0572, 0920-0572, 0920-0572, 0920-0572, 0920-0572,
0920-0572
Attachment 4 -
Provider Screener_1_13 , Attachment 5 - Provider
Survey_1_13 , Attatchment 6 -
FGPRScreener_1_13 , Attachment 7 -
FGPRGuide_1-13-17 , ttachment2 - Consumer Screener
for IDICONUS_1_13 , Attachment 3 consumer IDI
Guide_l1_13
Interim Assessment of
Messages for the Prescription Drug Overdose Prevention, Awareness,
and Knowledge Building Campaign
N/A
Screen Shots of the
Prescription Drug Overdose Survey
Bring Your Brave
Campaign Message Testing
none
Bring Your Brave
Campaign Testing Survey
HEADS UP Audience
Research Study
NA, NA
FOCUS GROUP
SCREENER AND FOLLOW UP FOCUS GROUP SCREENER , FOCUS GROUP AND FOLLOW UP FOCUS
GROUP INSTRUMENT
Air Quality
Information Initiative
none
Recruitment
screener
Domestic Readiness
Initiative on Zika Virus Disease - Year 2 Core Campaign
Materials
NA, NA
Focus Group
Screener , Focus Group Guide
Focus Group Research
to Inform the Development of Mesages to change Social
Norms
Att. F2, Att. F1
Att. F1 Dads book ,
Att. F2 Moms
book
Message testing among
partners of pregnant women in Puerto Rico
NA, NA
Intercept
Interviews with Public Audiences in Puerto Rico to test Zika
Prevention Messages - English , Intercept Interviews with
Public Audiences in Puerto Rico to test Zika Prevention Messages -
Spanish
Re-entry Messaging
Following a Radiation Emergency
Older Adult Mobility
Planning Brochure
none
Participant Screener
Domestic Readiness
Initiative on Zika Virus Disease: Year 2 Message & Materials
Testing
NA, NA, NA, NA
Community Leader -
Focus Group Screening Instrument , Men/Women Reproductive Age
(18-49) - Focus Group Screening Instrument , Community Leader - Focus Group
Guide , Men/Women Reproductive Age
(18-49) - Focus Group Guide
CDC/NCEH TO21: Outdoor
Air Quality Focus Group
"Bring Your Brave"
Campaign Messages for Young Women and Health Care
Providers
0920-0572, 0920-0572, 0920-0572, 0920-0572
Screening
Instrument for Young Women , Survey Instrument for Young
Women , Screening Instrument for Health
Care Providers , Survey Instrument for Health
Care Providers
Sepsis Educational
Awareness Message/Materials Assessment - HCP
none
Sepsis Educational
Awareness Assessment
Sepsis Campaign
Development: Round 2 Concept/Materials Testing for Healthcare
Providers
n/a
Screenshots of the
Sepsis Survey for Healthcare Professionals
HMTS - Message testing
among important public audiences in Puerto Rico
NA
Intercept
Interviews with Public Audiences in Puerto Rico to test Zika
Prevention Messages
Intercept Interviews
with Travelers in Puerto Rico To Test Zika Prevention
Messages
NA, NA
Intercept
Interviews with Public Audiences in Puerto Rico To Test Zika
Prevention Messages - English , Intercept Interviews with
Public Audiences in Puerto Rico To Test Zika Prevention Messages -
Spanish
Sepsis Educational
Awareness Message/Materials Assessment - Consumers
none
Sepsis Assessment -
Consumers
Radiation
Concepts/Comparison Message Testing
none, none
Interview
Screener , Focus Group Screener
Office of the
Associate Director for Communication (OADC) Message and Material
Feedback
NA, NA
OADC Message and
Material Feedback Survey - Screener , OADC Message and Material
Feedback Survey - Health Material Questions
Message Testing with
Mothers for CDC's Division of Nutrition, Physical Activity, and
Obesity (DNPAO)
n/a, n/a
Screener and Survey
for Online Participants (content is provided in screen shots and
Word) , Screener and Moderator's Guide
for In-person Focus Group Participants
Assess Perception and
Use of CDC Guideline for Prescribing Opioids for Chronic
Pain
none
CDC Prescription Opioid
Physician Survey
Skin Cancer Messages
among Racial Ethnic Groups at Risk for Delayed Diagnosis, Advanced
Disease and Lower Survival
N/A, N/A, N/A, N/A, N/A, N/A, N/A
Screener ,
Informed Consent
and Rescreening Form , Focus Group Discussion Guide
for African American Women , Focus Group Discussion Guide
for Hispanic Women , Focus Group Discussion Guide
for African American Men , Focus Group Discussion Guide
for Hispanic Men , Digital Ad Response Sheet
(completed during focus groups with men)
Antibiotic Use
Campaign: Round 2 (R2) Concept/Materials Testing with
Consumers
n/a, n/a, n/a, n/a, n/a
Pre-discussion
Information Survey for Consumers (Self-demanders and
Self-expectors) , Pre-discussion Information
Survey for Consumers (Caregiver-demanders and
Caregiver-expectors) , Online Focus Group Guide for
Consumers , Screener for Consumers
(Self-demanders and Self-expectors) , Screener for Consumers
(Caregiver-demanders and Caregiver-expectors)
Antibiotic Use
Campaign: Round 2 (R2) Concept/Materials Testing with Health Care
Professionals
n/a, n/a, n/a
Screener for Health
Care Professionals , Pre-Discussion Information
Survey for Health Care Professionals , In-Depth Interview Guide for
Health Care Professionals
Message Testing among
Public Audiences in US Virgin Islands for Zika prevention
none
Intercept interview
for message testing
Asthma Control
Communication Materials Field Testing (NCEH)
none, none, none, none, none
Foduc Group
Screener ,
Youth Rating
Worksheet , Caregiver Rating Worksheet
, Youth
Comparison Worksheet , Caregiver Comparison
Worksheet
Be Antibiotics Aware
Educational Message/Materials Assessment
n/a
Be Antibiotics
Aware Consumer Survey (BAACS)
Sepsis Campaign
Development: Round 2 Concept/Materials Testing for
Consumers
n/a
Screenshots of the
Sepsis R2 Survey for Consumers
American Academy of
Pediatrics Oral Health Toolkit Research and Message
Testing
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in
Estimate
Change Due to Potential Violation of
the PRA
Annual Number of Responses
55,575
55,575
0
0
0
0
Annual Time Burden (Hours)
7,410
7,510
0
-100
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency
Discretion: No
Burden Increase Due to:
Burden decreases because of Program Change due to Agency
Discretion: Yes
Burden Reduction Due to: Miscellaneous
Actions
Short Statement: Burden change reverts estimated
numbers back to original ICR; additional hours were added
previously due to an unusually burdensome genIC.
Annual Cost to Federal Government:
$1,550,000
Does this IC contain surveys, censuses, or employ
statistical methods? Yes Part B of Supporting Statement
Is the Supporting Statement intended to be a Privacy
Impact Assessment required by the E-Government Act of 2002?
No
Is this ICR related to the Affordable Care Act [Pub. L.
111-148 & 111-152]? No
Is this ICR related to the Dodd-Frank Wall Street Reform
and Consumer Protection Act, [Pub. L. 111-203]? No
Is this ICR related to the American Recovery and
Reinvestment Act of 2009 (ARRA)? No
Is this ICR related to the Pandemic Response?
Uncollected
Agency Contact: Shari Steinberg 404 639-4942
sxw2@cdc.gov